Journey Medical (DERM) Institutional Ownership $7.42 -0.12 (-1.59%) Closing price 04/30/2025 04:00 PM EasternExtended Trading$7.30 -0.12 (-1.55%) As of 08:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Journey Medical (NASDAQ:DERM)CurrentInstitutional OwnershipPercentage7.25%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$11.63MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$1.32M Get DERM Insider Trade Alerts Want to know when executives and insiders are buying or selling Journey Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DERM Institutional Buying and Selling by Quarter Journey Medical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/22/2025 Cambridge Investment Research Advisors Inc.338,050$1.99M0.0%+3.0%1.463% 2/17/2025Tang Capital Management LLC1,725,569$6.75M0.4%N/A8.260% 2/17/2025Cetera Investment Advisers13,839$54K0.0%+21.8%0.066% 2/17/2025Citadel Advisors LLC44,568$174K0.0%N/A0.213% 2/14/2025Kovitz Investment Group Partners LLC24,710$97K0.0%+112.9%0.118% 2/14/2025Integrated Wealth Concepts LLC58,850$230K0.0%-4.1%0.282% 2/14/2025Dimensional Fund Advisors LP20,455$80K0.0%N/A0.098% 2/13/2025Renaissance Technologies LLC236,000$923K0.0%-12.0%1.130% 2/13/2025Titleist Asset Management LLC10,900$43K0.0%-23.5%0.052% 2/13/2025 Envestnet Asset Management Inc.103,557$405K0.0%-5.5%0.496% Get the Latest News and Ratings for DERM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. 1/29/2025Gladstone Institutional Advisory LLC29,981$117K0.0%-10.5%0.144% 11/25/2024PVG Asset Management Corp167,545$947K3.8%+5.7%0.802% 11/16/2024Geode Capital Management LLC108,435$613K0.0%+13.5%0.523% 11/15/2024Kovitz Investment Group Partners LLC11,605$66K0.0%N/A0.056% 11/14/2024Walleye Capital LLC23,098$131K0.0%-63.7%0.111% 11/12/2024Nwam LLC10,430$59K0.0%N/A0.050% 11/1/2024Atria Investments Inc44,397$251K0.0%-19.8%0.214% 10/30/2024Rosalind Advisors Inc.105,917$598K0.4%-7.2%0.529% 10/11/2024 ORG Wealth Partners LLC19,519$110K0.0%N/A0.094% 8/22/2024PVG Asset Management Corp158,540$894K3.5%N/A0.792% 8/9/2024Renaissance Technologies LLC264,025$1.49M0.0%-2.4%1.319% 8/8/2024TMD Wealth Management LLC11,605$65K0.0%N/A0.058% 8/6/2024Acadian Asset Management LLC94,404$531K0.0%-57.6%0.472% 7/26/2024 Cambridge Investment Research Advisors Inc.294,950$1.66M0.0%N/A1.474% 7/12/2024Rosalind Advisors Inc.114,132$644K0.5%N/A0.570% 5/14/2024Heron Bay Capital Management33,669$124K0.0%N/A0.169% 5/10/2024Acadian Asset Management LLC222,663$817K0.0%+687.5%1.117% 5/10/2024Perkins Capital Management Inc.22,000$81K0.1%-31.3%0.110% 5/10/2024Nwam LLC11,820$41K0.0%N/A0.059% (Data available from 1/1/2016 forward) DERM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DERM shares? During the previous two years, 22 institutional investors and hedge funds held shares of Journey Medical. The most heavily invested institutionals were Tang Capital Management LLC ($6.75M), Cambridge Investment Research Advisors Inc. ($1.99M), PVG Asset Management Corp ($947K), Renaissance Technologies LLC ($923K), Geode Capital Management LLC ($613K), Rosalind Advisors Inc. ($598K), and Acadian Asset Management LLC ($531K).Learn more on DERM's institutional investors. What percentage of Journey Medical stock is owned by institutional investors? 7.25% of Journey Medical stock is owned by institutional investors. Learn more on DERM's institutional investor holdings. Which institutional investors have been buying Journey Medical stock? Of the 14 institutional investors that purchased Journey Medical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($1.73M), Cambridge Investment Research Advisors Inc. ($304.89K), Acadian Asset Management LLC ($194.39K), PVG Asset Management Corp ($167.55K), Rosalind Advisors Inc. ($114.13K), Citadel Advisors LLC ($44.57K), and Heron Bay Capital Management ($33.67K). How much institutional buying is happening at Journey Medical? Institutional investors have bought a total of 2,698,659 shares in the last 24 months. This purchase volume represents approximately $11.63M in transactions. Which Journey Medical major shareholders have been selling company stock? Of the 10 institutional investors that sold Journey Medical stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Acadian Asset Management LLC ($128.26K), Walleye Capital LLC ($40.48K), Renaissance Technologies LLC ($38.78K), Atria Investments Inc ($10.94K), Perkins Capital Management Inc. ($10K), Rosalind Advisors Inc. ($8.22K), and Envestnet Asset Management Inc. ($6.03K). How much institutional selling is happening at Journey Medical? Institutional investors have sold a total of 252,049 shares in the last 24 months. This volume of shares sold represents approximately $1.32M in transactions. Related Companies Trevi Therapeutics Institutional Ownership Keros Therapeutics Institutional Ownership Pharming Group Institutional Ownership Valneva Institutional Ownership Organogenesis Institutional Ownership CorMedix Institutional Ownership Opthea Institutional Ownership Upstream Bio Institutional Ownership Bicycle Therapeutics Institutional Ownership Immatics Institutional Ownership This page (NASDAQ:DERM) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DERM Stock Free DERM Stock Alerts